Acrivon Therapeutics (ACRV) Begins U.S. IPO Rollout : vimars

Acrivon Therapeutics has filed to raise $119 million in an IPO, although the final figure may differ. Click here to learn more about ACRV IPO.

Related Keywords

Wellington , New Zealand General , New Zealand , Peter Blume Jensen , Piper Sandler , Morgan Stanley , Company Pipeline , Xtuit Pharmaceuticals , Astrazeneca , Perceptive Life Sciences , Sands Capital Life Sciences , Shouya Holdings , Massachusetts Based Acrivon Therapeutics , Chief Scientific Officer , Chione Limited , Wellington Biomedical , Sands Capital Life , Compound Annual Growth Rate , Statement Of Operations ,